Tomosynthesis for breast cancer surgery
Tomosynthesis system technology that creates 3D images that enable surgeons to identify healthy tissue in breast cancer surgery.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Cancer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Tomosynthesis system technology that creates 3D images that enable surgeons to identify healthy tissue in breast cancer surgery.
- Key Point: Vikram Butani is the CEO of Kubtec, a Stratford CT based medical device company which he founded in 2005.
- Key Point: Vikram created a vision of a small dynamic organization founded on the principles or rapid innovation of proprietary technology solutions that have a real impact on the quality …
- Key Point: Through KUBTEC, Vikram holds patents in many different areas of image delivery for the practice of surgical oncology, including the use of intraoperative tomosynthesis for breas…
- Key Point: John Leach joined KUBTEC in 2015 as Vice President of Marketing.
Vikram Butani is the CEO of Kubtec, a Stratford CT based medical device company which he founded in 2005. Vikram created a vision of a small dynamic organization founded on the principles or rapid innovation of proprietary technology solutions that have a real impact on the quality of care for breast cancer patients. Through KUBTEC, Vikram holds patents in many different areas of image delivery for the practice of surgical oncology, including the use of intraoperative tomosynthesis for breast cancer surgery.
John Leach joined KUBTEC in 2015 as Vice President of Marketing. In this position, John has been central for the creation of key clinical evidence to support the adoption of the KUBTEC Mozart Specimen Tomosynthesis System.
Prior to joining KUBTEC John was Director of Strategy at Covidien Surgical Solutions, and previously Director of Global Marketing at Bayer Corporation.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.



